The first patient has been dosed in a phase 1 dose-finding clinical trial evaluating iadademstat with Vidaza in patients with ...

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): A rare and aggressive hematologic malignancy characterized by the proliferation of precursors of plasmacytoid dendritic cells. Clonal ...

The models were tested in the context of myeloproliferative neoplasms, a group of chronic hematologic malignancies in which the bone marrow makes too many red blood cells, white blood cells ...

Exploring the combination with azacitidineStudy led by Medical College of Wisconsin MADRID and CAMBRIDGE, Mass., Jan. 23, 2025 (GLOBE NEWSWIRE) -- (ISIN Code: ES0167733015, ORY), a clinical-stage ...

Hematologic and biochemical determinations ... 12 Twelve patients with disseminated testicular neoplasms of germinal origin were treated with mithramycin (Table 2). Objective regressions were ...

Myeloproliferative neoplasms (MPNs) are rare blood cancers ... and 16 with MF is offered at a hematology/oncology faculty clinic and a weekly fellow clinic, according to a summary published ...